Nephrocare Health IPO: Complete Details, Timeline, Financials & How to Check Allotment

S
Saketh |
Nephrocare Health IPO: Complete Details, Timeline, Financials & How to Check Allotment

The Nephrocare Health IPO is one of the most anticipated offerings in the health IPO category, especially with the company being among the fastest-growing dialysis clinics operators in India.

Backed by strong investors like Bessemer Venture Partners Trust, Investcorp Growth Opportunity Fund, and Edoras Investment Holdings Pte, Nephrocare Health Services Ltd has built a reputation for clinical excellence, operational efficiency, and patient-centric care across Tier II and Tier III cities.

With a growing network of clinics across states and 4 union territories and expansion into international markets such as Philippines, Uzbekistan, and Nepal, the company is aiming for sustained, technology-led growth in Asian healthcare.


Nephrocare Health IPO – Complete Details, Timeline, Financials & How to Check Allotment

This blog covers the Nephrocare Health IPO details, IPO date, IPO price band, financial performance, IPO allotment, and how retail investors can apply.

Nephrocare Health IPO Details

Detail Information
IPO Date December 10, 2025 to December 12, 2025
Face Value ₹2 per share
Health IPO Price Band ₹438 to ₹460 per share
Lot Size 32 Shares
Total Issue Size 1,89,35,819 shares (₹871.05 Cr)
Fresh Issue 76,82,717 shares (₹353.40 Cr)
Offer for Sale 1,12,53,102 shares (₹517.64 Cr)
Employee Discount ₹41 per share
Issue Type Bookbuilding IPO
Listing At BSE, NSE
Pre-Issue Shares 9,26,50,799
Post-Issue Shares 10,03,33,516

The Nephrocare Health IPO consists of a mix of fresh capital and OFS, aimed at scaling clinic operations, setting up new dialysis clinics, and scheduled repayment of borrowings availed.

Nephrocare Health IPO Timeline (IPO Date & Important Events)

Event Date
Nephrocare Health IPO Opens Wed, Dec 10, 2025
IPO Close Date Fri, Dec 12, 2025
IPO Allotment Mon, Dec 15, 2025
Initiation of Refunds Tue, Dec 16, 2025
Credit of Shares to Demat Tue, Dec 16, 2025
IPO Listing Date Wed, Dec 17, 2025
UPI Mandate Cut-off 5 PM on Dec 12

Company Overview – Nephrocare Health Services Ltd


Nephrocare Health IPO – Details Slide

Nephrocare Health Services Ltd is one of India’s largest and fastest-growing dialysis providers, operating a network of high-quality dialysis clinics, mobile dialysis units, wellness programs, and in-house pharmacies across 20+ states and multiple union territories.

The company is considered one of Asia’s emerging leaders in:

  • Sustainable dialysis leadership

  • Advanced technology, medical automation & organic growth

  • Internationally patient-centric leadership

  • Cost efficiencies and operational excellence

They have strong relationships with major hospitals including:

  • Care Hospitals

  • Ruby Hall Clinic

  • Jehangir Hospital

  • Fortis Escorts

Future plans include expanding to Philippines, Uzbekistan, Nepal, aligning with their vision to become Asia’s largest dialysis chain.

Business Overview – Dialysis Clinics & Healthcare Expansion

Dialysis Clinics

Nephrocare operates:

  • Standalone dialysis centers

  • Clinics inside partner hospitals

  • Mobile dialysis units for underserved areas

  • Clinics in Tier II and Tier III cities

The company focuses on reducing dependency on the world’s largest dialysis clinic chains and building a strong India-centric network.

International Markets

Nephrocare aims to scale into international markets with:

  • Regulatory compliance

  • Strong governance measures

  • Proven track record in multi-location operations

Capital Expenditure & Net Proceeds

The net proceeds will be used for:

  • Expanding new dialysis clinics

  • Setting up technology-enabled centers

  • Upgrading the software units layout

  • Scheduled repayment of borrowings

  • General corporate purposes

Anchor Investors & Private Equity Backing

Strong early interest has been seen from:

  • Investcorp Growth Opportunity Fund

  • Bessemer Venture Partners Trust

  • Edoras Investment Holdings Pte

  • Leading healthcare parent companies globally

This boosts confidence among retail investors and qualified institutional buyers.

Financial Information – Nephrocare Health Services Ltd

Period Ended 30 Sep 2025 31 Mar 2025 31 Mar 2024 31 Mar 2023
Assets 1,193.68 996.46 806.02 666.23
Total Income 483.97 769.92 574.72 443.26
Profit After Tax 14.23 67.10 35.13 -11.79
EBITDA 110.31 166.64 99.66 48.60
Net Worth 716.06 594.21 423.55 384.73
Reserves & Surplus 704.14 578.68 408.57 383.50
Total Borrowing 207.04 225.80 243.37 196.21

Amount in ₹ Crore


Nephrocare Health IPO – Slide

Key Takeaways

  • Revenue increased 34% YoY

  • PAT surged 91%, showing strong operational improvement

  • Steady increase in assets due to clinic expansion

  • Debt levels improving with scheduled repayment plans

IPO Allotment – How to Check Nephrocare Health IPO Allotment Status

You can check Nephrocare Health IPO allotment via:

KFin Technologies Ltd (Registrar)

Visit the official KFinTech allotment link and select Nephrocare Health IPO from the dropdown.

BSE IPO Allotment Page

Select issue name → Enter PAN or application number.

Your Broker App

Many apps show allotment under "IPO applications".

Keywords covered:

IPO allotment, Nephrocare Health IPO allotment, allotment status, IPO allotment status, check Nephrocare Health.

IPO Listing – IPO Listing Date & Market Expectations

  • IPO Listing Date: December 17, 2025

  • Shares will list on both BSE and NSE.

Listing may attract attention from both domestic and international investors due to:

  • Strong sector (kidney care & dialysis)

  • Backing from global investors

  • Expanding international presence

How Retail Investors Can Apply (Demat + UPI)

To apply for the Nephrocare Health IPO, investors need:

  • Active demat account

  • UPI ID

  • Minimum order quantity of 32 shares

Steps:

  • Open your broker app (Zerodha, Groww, AngelOne, etc.)

  • Search Nephrocare Health IPO

  • Enter bid – floor price, cap price, or custom price

  • Approve UPI mandate

  • Wait for allotment & listing

Conclusion

The Nephrocare Health IPO stands out in the health IPO category thanks to its strong presence in the dialysis segment, proven track record, cost-efficient operating model, and expansion into international markets.

Its financial performance, scalable business model, and international collaborations make it compelling for long-term investors looking at the healthcare space.

However, investors should also evaluate regulatory risks, competitive intensity, and global expansion timelines before applying.

Apply for your next IPO seamlessly on CubePlus by Tradejini : https://cubeplus.tradejini.com/app/orders/ipo


Disclaimer: The information provided in our blogs is for informational purposes only and should not be construed as financial, investment, or trading advice. Trading and investing in the securities market carries risk. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. Copyrighted and original content for your trading and investing needs.

© 2025 — Tradejini. All Rights Reserved.

Handpicked For You

Discover more premium content tailored to enhance your financial knowledge